ZimVie (NASDAQ:ZIMV) Posts Quarterly Earnings Results

ZimVie (NASDAQ:ZIMVGet Free Report) issued its quarterly earnings data on Thursday. The company reported $0.13 EPS for the quarter, Zacks reports. The business had revenue of $116.81 million for the quarter. ZimVie had a negative net margin of 56.31% and a positive return on equity of 2.01%. During the same quarter in the previous year, the business earned $0.17 earnings per share. ZimVie updated its FY 2024 guidance to 0.550-0.700 EPS.

ZimVie Stock Down 15.2 %

NASDAQ:ZIMV traded down $3.10 on Friday, hitting $17.30. 1,722,827 shares of the company’s stock were exchanged, compared to its average volume of 357,469. The firm has a 50-day moving average price of $18.04 and a 200-day moving average price of $17.53. ZimVie has a 52 week low of $6.52 and a 52 week high of $22.40. The company has a debt-to-equity ratio of 1.32, a current ratio of 2.68 and a quick ratio of 2.23. The company has a market cap of $472.12 million, a P/E ratio of -1.28 and a beta of 2.17.

Analysts Set New Price Targets

Separately, Needham & Company LLC increased their price objective on ZimVie from $20.00 to $23.00 and gave the stock a “buy” rating in a report on Friday.

Get Our Latest Stock Analysis on ZimVie

ZimVie Company Profile

(Get Free Report)

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

Featured Articles

Earnings History for ZimVie (NASDAQ:ZIMV)

Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.